Concordia International (formerly AMCo) is a diverse, international pharmaceutical company focused on legacy medicines and orphan drugs. We have a strong international footprint with sales in more than 100 countries, and a diversified portfolio of more than 200 well-established off-patent molecules. We supply niche medicines that make a real difference to the patients, doctors, hospitals and healthcare authorities we serve. We are building our portfolio of medicines through acquisition, in-licensing and internal developments. In the UK we contribute actively to a highly effective generics industry which is estimated to save the UK’s NHS c.£13.5 billion pounds in healthcare costs each year (source: British Generic Manufacturers Association) .